Related Experiment Video
Updated: Mar 15, 2026
04:51
Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
10.6K
Electroconvulsive therapy in a patient with glaucoma.
Ameya Amritwar1, Sagar Karia1, Avinash De Sousa1
1Department of Psychiatry, Lokmanya Tilak Municipal Medical College, Mumbai, Maharashtra, India.
The National Medical Journal of India
|September 3, 2016
Summary
Electroconvulsive therapy (ECT) can be safely used in patients with glaucoma. A case study showed no adverse ophthalmic events in an elderly patient with glaucoma undergoing ECT for severe depression.
Area of Science:
- Ophthalmology
- Neuroscience
- Psychiatry
Background:
- Limited data exists on electroconvulsive therapy (ECT) use in patients with glaucoma.
- Glaucoma and cataract surgery can impact ocular health and require careful patient management.
Observation:
- An elderly male patient with severe depression underwent cataract and glaucoma surgery on his left eye.
- Postoperatively, his depression symptoms exacerbated, necessitating two ECT sessions within two months.
Findings:
- Electroconvulsive therapy (ECT) was administered without any reported ophthalmic complications or adverse events.
- The patient demonstrated a positive clinical response to the ECT treatment for his severe depression.
Implications:
- This case suggests that ECT may be a viable treatment option for severe depression in patients with glaucoma.
- Further research is warranted to establish the safety and efficacy of ECT in this specific patient population.
Related Concept Videos
01:30Electroconvulsive Therapy
1.8K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.8K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
01:25Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
01:20Antiepileptic Drugs: Potassium Channel Activators
895
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
895